JP2010532157A5 - - Google Patents

Download PDF

Info

Publication number
JP2010532157A5
JP2010532157A5 JP2010502098A JP2010502098A JP2010532157A5 JP 2010532157 A5 JP2010532157 A5 JP 2010532157A5 JP 2010502098 A JP2010502098 A JP 2010502098A JP 2010502098 A JP2010502098 A JP 2010502098A JP 2010532157 A5 JP2010532157 A5 JP 2010532157A5
Authority
JP
Japan
Prior art keywords
recombinant
turkey herpesvirus
influenza virus
avian
herpesvirus according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502098A
Other languages
English (en)
Japanese (ja)
Other versions
JP5508252B2 (ja
JP2010532157A (ja
Filing date
Publication date
Priority claimed from US11/729,978 external-priority patent/US20080241188A1/en
Application filed filed Critical
Publication of JP2010532157A publication Critical patent/JP2010532157A/ja
Publication of JP2010532157A5 publication Critical patent/JP2010532157A5/ja
Application granted granted Critical
Publication of JP5508252B2 publication Critical patent/JP5508252B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502098A 2007-03-30 2008-03-28 鳥インフルエンザ遺伝子を含有する組み換え七面鳥ヘルペスウイルス Active JP5508252B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/729,978 US20080241188A1 (en) 2007-03-30 2007-03-30 Turkey herpesvirus vectored recombinant containing avian influenza genes
US11/729,978 2007-03-30
PCT/US2008/004070 WO2008121329A2 (en) 2007-03-30 2008-03-28 Turkey herpesvirus vectored recombinant containing avian influenza genes

Publications (3)

Publication Number Publication Date
JP2010532157A JP2010532157A (ja) 2010-10-07
JP2010532157A5 true JP2010532157A5 (enExample) 2011-05-19
JP5508252B2 JP5508252B2 (ja) 2014-05-28

Family

ID=39794757

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502098A Active JP5508252B2 (ja) 2007-03-30 2008-03-28 鳥インフルエンザ遺伝子を含有する組み換え七面鳥ヘルペスウイルス

Country Status (7)

Country Link
US (4) US20080241188A1 (enExample)
EP (1) EP2129390B1 (enExample)
JP (1) JP5508252B2 (enExample)
CN (1) CN101903040A (enExample)
ES (1) ES2399845T3 (enExample)
PL (1) PL2129390T3 (enExample)
WO (1) WO2008121329A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008140557A2 (en) 2006-10-24 2008-11-20 Samuel Bogoch A method of predicting influenza outbreaks
MX2009013091A (es) 2007-05-30 2010-07-30 Bogoch Samuel Peptidos de repliquina sinteticos contra infeccion patogenica de invertebrados en acuicultura.
MX2010013693A (es) * 2008-06-23 2010-12-21 Intervet Int Bv Virus de herpes recombinante de pavos que codifica para interleucina-12.
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
CN105567648B (zh) * 2009-04-15 2019-09-03 法国诗华大药厂 用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗
NZ595812A (en) * 2009-04-23 2013-09-27 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
US8986987B2 (en) * 2010-10-18 2015-03-24 Intervet Inc. Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
EP2644702A1 (en) * 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
CN103740759B (zh) * 2014-01-20 2016-04-06 中国农业科学院哈尔滨兽医研究所 表达h5n1亚型禽流感病毒ha基因的重组火鸡疱疹病毒
US10179229B2 (en) 2014-12-23 2019-01-15 Edge Systems Llc Devices and methods for treating the skin using a porous member
EP3471766B1 (en) 2016-06-17 2022-12-14 Intervet International B.V. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens
CN106497893A (zh) * 2016-10-28 2017-03-15 扬州大学 表达H7N9亚型禽流感病毒嵌合型血凝素蛋白的重组火鸡疱疹病毒株rHMW及构建方法
CN106399267A (zh) * 2016-10-28 2017-02-15 扬州大学 表达H7N9亚型禽流感病毒血凝素蛋白的重组火鸡疱疹病毒株rHOH及构建方法
BR112020007213A2 (pt) 2017-10-12 2020-10-13 Intervet International B.V. construtos de vírus da doença de marek não patogênico recombinante que codificam múltiplos antígenos heterólogos
CN109142734B (zh) * 2018-10-26 2021-07-16 北京纳百生物科技有限公司 禽流感病毒H5亚型Re-6株抗体鉴定试剂盒
CN109402071B (zh) * 2018-11-08 2021-04-27 中国农业大学 一种表达h9n2亚型禽流感病毒h9蛋白的重组火鸡疱疹病毒
CN110205308A (zh) * 2019-05-24 2019-09-06 华南农业大学 一种表达ha基因的重组火鸡疱疹病毒及其应用
JP2023506919A (ja) * 2019-12-20 2023-02-20 インターベット インターナショナル ベー. フェー. 多価hvtベクターワクチン
WO2022079160A2 (en) 2020-10-15 2022-04-21 Ceva Sante Animale Recombinant hvt and uses thereof
CN114184797B (zh) * 2021-12-06 2024-06-14 辽宁成大生物股份有限公司 一种流感病毒裂解疫苗单价原液血凝素的检测方法
USD1084369S1 (en) 2023-02-10 2025-07-15 Hydrafacial Llc Skin treatment tip

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5916879A (en) * 1996-11-12 1999-06-29 St. Jude Children's Research Hospital DNA transcription unit vaccines that protect against avian influenza viruses and methods of use thereof
WO1999018215A1 (en) * 1997-10-03 1999-04-15 Nippon Zeon Co., Ltd. Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US6866852B2 (en) * 2002-01-31 2005-03-15 Zeon Corporation Recombinant herpesvirus of turkeys and use thereof
ZA200508930B (en) * 2003-05-05 2007-03-28 Thompson Boyce Inst Plant Research Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
ES2620789T3 (es) * 2005-08-15 2017-06-29 Altimmune Inc. Inmunización de aves por administración de vacunas con vectores no replicantes

Similar Documents

Publication Publication Date Title
JP2010532157A5 (enExample)
Chen et al. Advances in development and application of influenza vaccines
Gu et al. Current situation of H9N2 subtype avian influenza in China
Li et al. Avian influenza vaccines against H5N1 ‘bird flu’
Lee et al. H9N2 avian influenza virus in Korea: evolution and vaccination
Kistner et al. Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
RU2018116857A (ru) Мультивалентные рекомбинантные вирусы птичьего герпеса и вакцины для иммунизации птиц
Bardiya et al. Influenza vaccines: recent advances in production technologies
JP2016155867A5 (enExample)
Xu et al. Phylogenetic classification of hemagglutinin gene of H9N2 avian influenza viruses isolated in China during 2012–2016 and evaluation of selected candidate vaccine strains
JP2015500806A5 (enExample)
JP2015119730A5 (enExample)
CN104232594B (zh) 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用
US20120269849A1 (en) Attenuated influenza viruses and vaccines
CA2604330A1 (en) Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
CN101636177A (zh) 用于禽流感的基于重组改良型痘苗病毒安卡拉(mva)的疫苗
Jang et al. Principles underlying rational design of live attenuated influenza vaccines
JP2012511914A5 (enExample)
EP2432503A1 (en) Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva)
US11510976B2 (en) H7 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application
JP2016501020A5 (enExample)
Umar et al. Emerging threat of H9N2 viruses in poultry of Pakistan and vaccination strategy
Kim et al. Recent outbreaks of highly pathogenic avian influenza viruses in South Korea
Deng et al. Developments of subunit and VLP vaccines against influenza A virus
Steel New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges